Cancer Network Podcasts
MBCC: Next Generation Treatment for Triple-Negative and Basal-Cell Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:07:51
- Mas informaciones
Informações:
Sinopsis
The early promise of treating triple-negative and basal-cell breast cancers with poly (ADP-ribose) polymerase (PARP) inhibitors is yet to be realized, according to Lisa A. Carey, MD, who will be delivering a presentation on treatment options for these patients at the Miami Breast Cancer Conference this week.
